Skip to main content
Article

A randomized study of temozolomide (TMX) alone, with interferon-alpha (TMZ-IFN) or with thalidomide (TMZ-THL) in metastatic malignant melanoma (MMM)

  • Danson S
  • Arance A
  • Lorigan P
  • et al.
Proceedings of the american society of clinical oncology
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

38th Annual Meeting of the American Society of Clinical Oncology; 18-21 May 2002; Orlando, Florida, USA

Cite

CITATION STYLE

APA

Danson, S., Arance, A., Lorigan, P., Clamp, A., Hodgetts, J., Lomax, L., … Middleton, M. (2002). A randomized study of temozolomide (TMX) alone, with interferon-alpha (TMZ-IFN) or with thalidomide (TMZ-THL) in metastatic malignant melanoma (MMM). Proceedings of the American Society of Clinical Oncology. Retrieved from http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/614/CN-00695614/frame.html NS  -

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free